Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C2B | O00750 | 7/20 | 0.40 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.36 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.35 |
| ▸ | BCL2 | P10415 | 4/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.34 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | USP7 | Q93009 | 2/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | LTA4H | P09960 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6487283 | 0.92 | PIK3C2B (0.35) | PIK3C2BPIK3CBUSP7 | |
| SCHEMBL6488053 | 0.92 | BCL2 (0.43) | PIK3C2BPIK3CBTRPM4BCL2MCL1 | |
| SCHEMBL6500310 | 0.89 | ALOX5AP (0.40) | TRPM4ALOX5APALOX5PPARG | |
| SCHEMBL6500643 | 0.88 | ALOX5AP (0.40) | PIK3C2BBCL2MCL1ALOX5APALOX5 | |
| SCHEMBL6488587 | 0.87 | BCL2 (0.37) | PIK3C2BTRPM4BCL2MCL1 | |
| SCHEMBL6491035 | 0.84 | LTA4H (0.41) | PIK3C2BTRPM4MCL1USP7PPARG | |
| SCHEMBL6502905 | 0.83 | PIK3C2B (0.41) | PIK3C2BPIK3CBBCL2MCL1ALOX5AP | |
| SCHEMBL6488725 | 0.81 | ALOX5AP (0.37) | ALOX5APPPARG | |
| SCHEMBL6496471 | 0.81 | DCTPP1 (0.37) | PIK3C2BBCL2MCL1ALOX5APPPARG | |
| SCHEMBL6503527 | 0.81 | PIK3C2B (0.38) | PIK3C2BBCL2MCL1ALOX5APALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014812-A1 | Benzimidazole compounds | SLC5A1, SLC5A2, G6PD | PIK3C2B 2433/4885PIK3CB 1157/4885TRPM4 2577/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.